US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bionoid Pharma Inc.

0.0330

+0.016094.12%

Volume:184.41K

Turnover:4.97K

Market Cap:1.78M

PE:0.00

High:0.0360

Open:0.0199

Low:0.0199

Close:0.0170

52wk High:0.4480

52wk Low:0.0162

Shares:53.99M

Float Shares:6.84M

Volume Ratio:4.64

T/O Rate:2.70%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-46.2733

EPS(LYR):-46.2733

ROE:--

ROA:-164.12%

PB:-1.56

PE(LYR):0.00

Loading ...

Overview Company News Filings

AI Maverick Intel Transforms from Bionoid Pharma Inc. to AI-First Innovator

Ibn Initiates Coverage of AI Maverick Intel Inc.

THOMSON REUTERS

IBN Initiates Coverage of AI Maverick Intel Inc., Boosting Corporate Communications Efforts

Bionoid Pharma Rebrands as AI Maverick Intel, Inc. Following Delaware Approval

Bionoid Pharma Inc. Rebrands as AI Maverick Intel, Inc

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BINP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BINP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BINP\",,,,,undefined,":{"symbol":"BINP","market":"US","secType":"STK","nameCN":"Bionoid Pharma Inc.","latestPrice":0.033,"timestamp":1755633600000,"preClose":0.017,"halted":0,"volume":184410,"delay":15,"floatShares":6835488,"shares":53994600,"eps":-46.273344,"marketStatus":"Post-Mkt","change":0.016,"latestTime":"08-19 16:00:00 EDT Delay","open":0.0199,"high":0.036,"low":0.0199,"amount":4973.4578,"amplitude":0.947059,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-46.273344,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1755648000000},"marketStatusCode":4,"adr":0,"exchange":"PINK","adjPreClose":0.017,"volumeRatio":4.640436},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BINP\",,,,,undefined,":{"symbol":"BINP","floatShares":6835488,"roa":"-164.12%","roe":"--","lyrEps":-46.273344,"volumeRatio":4.640436,"shares":53994600,"dividePrice":0,"high":0.036,"amplitude":0.947059,"preClose":0.017,"low":0.0199,"week52Low":0.0162,"pbRate":"-1.56","psRate":"19.31","week52High":0.448,"institutionHeld":0,"latestPrice":0.033,"eps":-46.273344,"divideRate":0,"volume":184410,"delay":15,"ttmEps":-46.273344,"open":0.0199,"prevYearClose":0.308,"prevWeekClose":0.0268,"prevMonthClose":0.023,"prevQuarterClose":0.04,"fiveDayClose":0.022,"twentyDayClose":0.03,"sixtyDayClose":0.1077},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BINP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BINP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BINP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BINP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2558479226","title":"AI Maverick Intel Transforms from Bionoid Pharma Inc. to AI-First Innovator","url":"https://stock-news.laohu8.com/highlight/detail?id=2558479226","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558479226?lang=en_us&edition=fundamental","pubTime":"2025-08-12 21:25","pubTimestamp":1755005114,"startTime":"0","endTime":"0","summary":"AI Maverick Intel Inc., formerly known as Bionoid Pharma Inc., has undergone a name and identity change to reflect its new focus as an AI-first operator. The company aims to leverage its proprietary AI Maverick platform to pursue scalable automation opportunities in various high-value verticals.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ai Maverick Intel Inc. published the original content used to generate this news brief via ACCESS Newswire  on August 12, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nNDL29xF3j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2148611432.USD","LU0321505439.SGD","BK4527","BK4141","BINP","BK4612","BK4602","BK4534","BK4554","BK4515","BK4543","BK4550","BK4585","BK4512","LU2543165471.USD","BK4588","BK4605","BK4529","LU0321505868.SGD","BK4579","BK4533","BK4575","BK4535","LU0081259029.USD"],"gpt_icon":1},{"id":"2555404113","title":"Ibn Initiates Coverage of AI Maverick Intel Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2555404113","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555404113?lang=en_us&edition=fundamental","pubTime":"2025-07-30 20:30","pubTimestamp":1753878601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250730:nTUA6GXWZR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4527","BK4585","BK4515","BK4535","LU2148611432.USD","BK4534","BK4141","LU0321505439.SGD","BINP","BK4575","INTC","BK4605","BK4612","BK4602","BK4543","LU2543165471.USD","BK4588","BK4579","LU0321505868.SGD","BK4533","LU0081259029.USD","BK4550","BK4554","BK4512","BK4529"],"gpt_icon":0},{"id":"2555458000","title":"IBN Initiates Coverage of AI Maverick Intel Inc., Boosting Corporate Communications Efforts","url":"https://stock-news.laohu8.com/highlight/detail?id=2555458000","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555458000?lang=en_us&edition=fundamental","pubTime":"2025-07-30 19:00","pubTimestamp":1753873259,"startTime":"0","endTime":"0","summary":"AI Maverick Intel Inc.  has appointed IBN to manage its corporate communications. The collaboration aims to boost awareness of AI Maverick Intel's innovative platform that revolutionizes customer engagement through AI-driven prospecting. With IBN's extensive distribution network and a broad audience reach, AI Maverick Intel is set to enhance its visibility among investors and the public. For more information, visit ibn.fm/BINP.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ai Maverick Intel Inc. published the original content used to generate this news brief via ACCESS Newswire  on July 30, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250730:nNDL3MrwRC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","BK4550","BK4575","BK4543","BK4535","BK4602","BK4512","BK4534","LU0321505868.SGD","LU2543165471.USD","BK4612","BK4585","LU2148611432.USD","BINP","BK4588","BK4141","BK4527","BK4515","BK4579","LU0321505439.SGD","LU0081259029.USD","BK4529","BK4605","BK4554"],"gpt_icon":1},{"id":"2539878257","title":"Bionoid Pharma Rebrands as AI Maverick Intel, Inc. Following Delaware Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2539878257","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539878257?lang=en_us&edition=fundamental","pubTime":"2025-05-29 19:41","pubTimestamp":1748518862,"startTime":"0","endTime":"0","summary":"AI Maverick Intel, Inc., formerly known as Bionoid Pharma, Inc., has confirmed a name change following approval from the State of Delaware. The company is in the process of updating its name and trading symbol on the OTC Markets, pending FINRA's approval. This change aligns with the company's strategic focus on leveraging artificial intelligence to expand and innovate within technology-driven sectors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ai Maverick Intel Inc. published the original content used to generate this news brief via ACCESS Newswire  on May 29, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250529:nNDL4WK5BX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4612","LU2543165471.USD","BK4550","LU0081259029.USD","LU0321505868.SGD","BK4543","BK4535","BK4141","BK4534","BK4529","BK4533","BK4605","BK4579","BK4527","LU0321505439.SGD","BK4512","BK4515","BK4554","BK4575","BK4602","BINP","BK4588","BK4585"],"gpt_icon":1},{"id":"2535396296","title":"Bionoid Pharma Inc. Rebrands as AI Maverick Intel, Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2535396296","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535396296?lang=en_us&edition=fundamental","pubTime":"2025-05-16 19:31","pubTimestamp":1747395105,"startTime":"0","endTime":"0","summary":"Bionoid Pharma Inc. has announced its rebranding as AI Maverick Intel, Inc., reflecting a strategic shift toward AI-driven innovation. This transformation underscores the company's commitment to revolutionizing customer acquisition and engagement in healthcare, biotech, and other sectors through advanced artificial intelligence technologies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bionoid Pharma Inc. published the original content used to generate this news brief via ACCESS Newswire  on May 16, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250516:nNDL4bs2kv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BINP","LU2543165471.USD","BK4141","BK4585","BK4550","BK4512","BK4588","BK4605","LU0321505868.SGD","BK4529","BK4527","LU0081259029.USD","LU0321505439.SGD","BK4543","BK4602","BK4554","BK4579","BK4535","BK4515","BK4575","BK4533","BK4534","BK4612"],"gpt_icon":1}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}]}}